Chemistry,
Journal Year:
2024,
Volume and Issue:
6(4), P. 677 - 694
Published: Aug. 3, 2024
Aaptamine
(8,9-dimethoxy-1H-benzo[de][1,6]naphthyridine),
an
alkaloid
obtained
from
marine
sponges
of
the
genus
Aaptos
(Demospongiae,
Suberitida,
Suberitidae),
has
attracted
significant
attention
as
a
promising
scaffold
for
development
antioxidant,
antibacterial,
and
anticancer
agents.
This
review
offers
extensive
overview
updated
research
on
aaptamine,
focusing
its
multifaceted
pharmacological
properties.
The
antioxidant
potential
aaptamine
reflects
ability
use
in
DPPH
free
radical
scavenging
assay,
suppressing
ROS,
subsequently
deactivating
MAPK
AP-1
signaling
pathway.
Moreover,
it
demonstrates
notable
antibacterial
activity
against
pathogenic
bacteria,
including
mycobacterial
active
dormant
states,
making
candidate
combating
bacterial
infections.
Additionally,
shows
by
inhibiting
cancer
cell
proliferation,
apoptosis
induction,
tumor
growth
through
various
pathways,
regulation
PTEN/PI3K/Akt
CDK2/4,
cyclin
D1/E
cycle
arrest.
unique
chemical
structure
opportunities
structural
modifications
aimed
at
enhancing
activities.
exploration
novel
therapeutic
agents
great
promise
addressing
challenges
associated
with
oxidative
stress,
infections,
cancer.
article
underscores
valuable
marine-derived
fields
therapy.
Cells,
Journal Year:
2023,
Volume and Issue:
12(7), P. 986 - 986
Published: March 23, 2023
Continuous
monitoring
of
the
population’s
health
is
main
method
learning
about
disease
prevalence.
National
and
international
data
draw
attention
to
persistently
high
rates
cancer
incidence.
This
necessitates
intensification
efforts
aimed
at
developing
new,
more
effective
chemotherapeutic
chemopreventive
drugs.
Plants
represent
an
invaluable
source
natural
substances
with
versatile
medicinal
properties.
Multidirectional
activities
exhibited
by
their
ability
modulate
key
signaling
pathways,
mainly
related
cell
death,
make
these
important
research
direction.
review
summarizes
information
regarding
plant-derived
drugs,
including
mechanisms
action,
a
special
focus
on
selected
anti-cancer
drugs
(paclitaxel,
irinotecan)
approved
in
clinical
practice.
It
also
presents
promising
plant-based
drug
candidates
currently
being
tested
preclinical
trials
(betulinic
acid,
resveratrol,
roburic
acid).
Marine Drugs,
Journal Year:
2024,
Volume and Issue:
22(3), P. 126 - 126
Published: March 6, 2024
Indole
is
a
versatile
pharmacophore
widely
distributed
in
bioactive
natural
products.
This
privileged
scaffold
has
been
found
variety
of
molecules
isolated
from
marine
organisms
such
as
algae
and
sponges.
Among
these,
indole
alkaloids
represent
one
the
biggest,
most
promising
family
compounds,
having
shown
wide
range
pharmacological
properties
including
anti-inflammatory,
antiviral,
anticancer
activities.
The
aim
this
review
to
show
current
scenario
alkaloid
derivatives,
covering
not
only
common
chemical
structures
but
also
their
therapeutic
applications
well
new
general
synthetic
routes
developed
during
last
years.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1376 - 1376
Published: Feb. 6, 2025
Cancer
is
a
multifaceted
disease
characterised
by
uncontrolled
cellular
proliferation
and
metastasis,
resulting
in
significant
global
mortality.
Current
therapeutic
strategies,
including
surgery,
chemotherapy,
radiation
therapy,
face
challenges
such
as
systemic
toxicity
tumour
resistance.
Recent
advancements
have
shifted
towards
targeted
therapies
that
act
selectively
on
molecular
structures
within
cancer
cells,
reducing
off-target
effects.
Mitochondria
emerged
pivotal
targets
this
approach,
given
their
roles
metabolic
reprogramming,
retrograde
signalling,
oxidative
stress,
all
of
which
drive
the
malignant
phenotype.
Targeting
mitochondria
offers
promising
strategy
to
address
these
mechanisms
at
origin.
Synthetic
derivatives
natural
compounds
hold
particular
promise
mitochondrial-targeted
therapies.
Innovations
drug
design,
use
conjugates
nanotechnology,
focus
optimizing
for
mitochondrial
specificity.
Such
enhance
efficacy
while
minimizing
toxicity,
presenting
step
forward
modern
anticancer
strategies.
Nano Letters,
Journal Year:
2023,
Volume and Issue:
23(12), P. 5641 - 5647
Published: June 9, 2023
Acute
kidney
injury
(AKI)
is
a
common
clinical
syndrome
lacking
effective
pharmacotherapy.
Gambogic
acid
(GA),
as
an
active
ingredient
of
herbal
medicines,
exhibits
antioxidant
and
anti-inflammatory
effects
that
benefit
the
treatment
AKI,
but
its
poor
aqueous
solubility
limits
renal
delivery.
We,
for
first
time,
developed
GA-based
nanoparticles
(GA-NPs)
with
preferential
uptake
AKI
treatment.
By
PEGylating
NH2–PEG5000-NOTA,
hydrophobic
GA
was
self-assembled
into
∼4.5
nm
nanoparticles,
which
showed
enhanced
accumulation
in
models
from
PET
images.
Importantly,
vitro
cell
assays
vivo
tests
two
have
confirmed
obvious
nephroprotective
biosafety
GA-NPs.
Therefore,
this
work
indicates
GA-NPs
can
be
promising
therapeutic
candidate
management
AKI.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(4), P. 1106 - 1106
Published: April 6, 2023
Monkeypox
disease
(Mpox)
has
threatened
humankind
worldwide
since
mid-2022.
The
Mpox
virus
(MpoxV)
is
an
example
of
Orthopoxviruses
(OPVs),
which
share
similar
genomic
structures.
A
few
treatments
and
vaccines
are
available
for
Mpox.
OPV-specific
VP37
protein
(VP37P)
a
target
developing
drugs
against
other
OPV-induced
infections
such
as
smallpox.
This
review
spotlights
the
existing
prospective
VP37P
inhibitors
(VP37PIs)
non-patent
literature
was
collected
from
PubMed,
patent
gathered
free
databases.
Very
little
work
been
carried
out
on
VP37PIs.
One
VP37PI
(tecovirimat)
already
approved
in
Europe
to
treat
Mpox,
while
another
drug,
NIOCH-14,
under
clinical
trial.
Developing
tecovirimat/NIOCH-14-based
combination
therapies
with
clinically
used
demonstrating
activity
or
OPV
(mitoxantrone,
ofloxacin,
enrofloxacin,
novobiocin,
cidofovir,
brincidofovir,
idoxuridine,
trifluridine,
vidarabine,
fialuridine,
adefovir,
imatinib,
rifampicin),
immunity
boosters
(vitamin
C,
zinc,
thymoquinone,
quercetin,
ginseng,
etc.),
may
appear
promising
strategy
fight
infections.
Drug
repurposing
also
good
approach
identifying
useful
dearth
discovery
process
VP37PIs
makes
it
interesting
area
further
research.
development
hybrid
molecules
certain
chemotherapeutic
agents
looks
fruitful
can
be
explored
obtain
new
VP37PI.
It
would
challenging
develop
ideal
concerning
its
specificity,
safety,
efficacy.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(7), P. 922 - 922
Published: July 10, 2024
Cancer
remains
a
formidable
global
health
challenge,
with
current
treatment
modalities
such
as
chemotherapy,
radiotherapy,
surgery,
and
targeted
therapy
often
hindered
by
low
efficacy
adverse
side
effects.
The
indole
scaffold,
prominent
heterocyclic
structure,
has
emerged
promising
candidate
in
the
fight
against
cancer.
This
review
consolidates
recent
advancements
developing
natural
synthetic
indolyl
analogs,
highlighting
their
antiproliferative
activities
various
cancer
types
over
past
five
years.
These
analogs
are
categorized
based
on
common
types,
supported
biochemical
assays
demonstrating
properties.
In
this
review,
emphasis
is
placed
elucidating
mechanisms
of
action
these
compounds.
Given
limitations
conventional
therapies,
therapeutics
enhanced
selectivity
reduced
effects
critical
focus
oncological
research.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(3), P. 419 - 419
Published: March 16, 2025
Hepatitis
B
virus
(HBV)
is
an
important
global
public
health
issue.
The
World
Health
Organization
(WHO)
2024
Global
Report
estimated
that
the
prevalence
of
people
living
with
HBV
infection
254
million,
incidence
1.2
million
new
infections
yearly.
Previous
studies
have
shown
natural
compounds
antiviral
inhibition
potentials.
In
silico
methods
such
as
molecular
docking,
virtual
screening,
pharmacophore
modeling,
quantitative
structure–activity
relationship
(QSAR),
and
dynamic
simulations
been
successfully
applied
in
identifying
bioactive
strong
binding
energies
treatment
targets.
COVID-19
pandemic
necessitated
importance
repurposing
already
approved
drugs
using
methods.
This
study
aimed
at
unveiling
benefits
techniques
a
potential
alternative
compounds’
drug
discovery
for
therapy.
Relevant
articles
from
PubMed,
Google
Scholar,
Web
Science
were
retrieved
analyzed.
Furthermore,
this
comprehensively
reviewed
literature
containing
identified
essential
proteins.
Notably,
hesperidin,
quercetin,
kaempferol,
myricetin,
flavonoids
hepatitis
surface
antigen
(HBsAg).
investigation
reveals
offer
understanding
mechanisms
action,
reveal
previously
overlooked
viral
targets
(including
PreS1
Domain
HBsAg
cccDNA
(Covalently
Closed
Circular
DNA)
regulators,
facilitate
creation
specific
inhibitors.
integration
silico,
vitro,
vivo
insights
further
highlight
Moreover,
combination
compounds,
approach,
improves
chances
personalized
precision
medicine
treatment.
Therefore,
we
recommend
strategies
combine
vivo,
approaches
to
effective
drugs.